Pharmosa Biopharm Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Institutions | 3,905,667 | 3.03% |
| VC/PE Firms | 9,345,701 | 7.24% |
| Individual Insiders | 11,066,251 | 8.58% |
| Private Companies | 32,489,619 | 25.2% |
| General Public | 72,210,766 | 56% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.1%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 9,345,701 | NT$531.8m | 0% | 12.33% | |||
| 8,566,664 | NT$487.4m | 0% | no data | |||
| 7,340,324 | NT$417.7m | 0% | no data | |||
| 6,790,000 | NT$386.4m | 0% | no data | |||
| 5,592,631 | NT$318.2m | 0% | no data | |||
| 4,200,000 | NT$239.0m | 0% | no data | |||
| 3,986,030 | NT$226.8m | 0% | no data | |||
| 2,778,000 | NT$158.1m | 0% | 5.79% | |||
| 2,442,430 | NT$139.0m | 0% | no data | |||
| 2,345,442 | NT$133.5m | 0% | no data | |||
| 1,045,573 | NT$59.5m | 0% | no data | |||
| 919,903 | NT$52.3m | 0% | no data | |||
| 840,000 | NT$47.8m | 0% | no data | |||
| 486,870 | NT$27.7m | 0% | no data | |||
| 82,094 | NT$4.7m | 0% | no data | |||
| 45,576 | NT$2.6m | -18% | no data |